Clinical characteristics and transabdominal ultrasound features that associated with T3-T4 staging in gastric cancer: A retrospective study

Table 1 Patients characteristics and lesion profiles (n = 113)

Characteristics	N = 113
Age (years)	57.3 ± 11.9
BMI (kg/m2)	21.2 ± 3.2
Gender, n (%)
Male/female	71 (62.8)/42 (37.2)
Lesion thickness (cm)	1.5 ± 0.6
Lesion length (cm)	5.2 ± 2.3
Presence of angle sign, n (%)
Yes/no	89 (78.7)/24 (21.3)
Presence of ulcer, n (%)
Yes/no	63 (55.7)/50 (44.3)
Lesion location, n (%)
Gastric antrum	53 (46.9)
Gastric fundus	12 (10.6)
Gastric body	33 (29.3)
Gastric fundus + body	11 (9.7)
Gastric angle	4 (3.5)
Clinical feature, n (%)
Epigastrium discomfort or dull pain	36 (31.9)
Abdominal pain with black stool	18 (15.9)
Abdominal pain with belching	22 (19.5)
Abdominal distension with anorexia	17 (15.0)
Abdominal pain with vomiting	15 (13.3)
Dysphagia	5 (4.4)
CEA, n (%)
< 5 μg/L/≥ 5 μg/L	79 (69.9)/34 (30.1)
CA19-9, n (%)
< 37 kU/L/≥ 37 kU/L	85 (75.2)/28 (24.8)
Pathological type, n (%)
Adenocarcinoma	113 (100.0)
Histologic type, n (%)
Poor differentiated	71 (62.8)
Moderate differentiated	37 (32.8)
Well differentiated	5 (4.4)
Lauren type, n (%)
Diffuse type	70 (61.9)
Hybrid type	15 (13.3)
Intestinal type	28 (24.8)

BMI: Body mass index; CEA: Carcinoembryonic antigen.